Clinical trials
Recruiting Phase 1 Kidney Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arcus Biosciences, Inc. | 1 |
| Aurigene Discovery Technologies Limited | 1 |
| Brian Henick, MD | 1 |
| Bristol-Myers Squibb | 1 |
| Degron Therapeutics Co. | 1 |
| HiberCell, Inc. | 1 |
| KaliVir Immunotherapeutics | 1 |
| Kura Oncology, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Molecure S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 18 |
| Carcinoma, Renal Cell | 12 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colonic Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Esophageal Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.